Lilly's Bydureon falls short of competitor in study

























And the Eli Lilly FIPNET pipeline of innovation continues to amaze shareholders and strike fear in the hearts of competitors.

http://www.ibj.com/lillys-bydureon-falls-short-of-competitor-in-study/PARAMS/article/25656

P.S. Keep up the good work JL. Only a few million more and your net worth will break half a billion. You're a giant among insects.

Fear not, as our innovative pipeline runs deep and there will be no mass layoffs at Lilly. You have my word on it.

Honest John